Mario Scheel Werner
About Mario Scheel Werner
Mario Scheel Werner serves as the General Manager EMEA at Singular Genomics since 2023, bringing extensive experience in sales and management within the life sciences sector. He has held various leadership roles at notable companies, including Quanterix and 10x Genomics, and possesses a strong background in biology and business administration.
Current Role at Singular Genomics
Mario Scheel Werner serves as the General Manager EMEA at Singular Genomics since 2023. He operates from Berlin, Germany, and works remotely. In this role, he oversees the company's operations and strategic initiatives across the EMEA region, leveraging his extensive experience in the life sciences sector.
Previous Experience in Life Sciences
Before joining Singular Genomics, Mario held several significant positions in the life sciences industry. He was the General Manager Europe at Quanterix from 2022 to 2023. Prior to that, he worked at 10x Genomics in various roles, including Director Sales EMEA and Senior District Sales Manager DACH, contributing to the company's growth in the European market.
Educational Background
Mario Scheel Werner studied Biology with a focus on Genetics at FAU Erlangen-Nürnberg, where he achieved a Diplom from 1993 to 1999. He also pursued further education in business administration at FernUniversität in Hagen, earning a Certificate with a focus on business strategy, organization, and marketing in 2004. Additionally, he completed various certificates related to management and finance through the Institute of Directors and LinkedIn Learning.
Expertise in Business Development
Mario possesses extensive experience in building and organizing teams for business development, application, and technical support within the EMEA region. His broad knowledge of the European clinical and translational market is complemented by his strong analytical, creative, and communication skills, which are essential for adapting to new challenges.
Network and Industry Connections
Mario has developed a strong network of Key Opinion Leaders (KOLs) in the life sciences industry. His connections and relationships within the sector enhance his ability to identify and develop business opportunities in new market segments, contributing to his effectiveness in leadership roles.